Leti Pharma GmbH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

s.c. injection · Oncology
This drug targets the PD-1 receptor to modulate the immune response.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Leti Pharma GmbH portfolio CI brief
Leti Pharma GmbH pipeline updates RSS

Frequently asked questions about Leti Pharma GmbH

What is Leti Pharma GmbH's pipeline?

Leti Pharma GmbH has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include s.c. injection.

Sector hub: All tracked pharma companies